--- title: "12 Health Care Stocks Moving In Monday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/283385887.md" description: "In Monday's intraday session, Enveric Biosciences (ENVB) saw a significant gain of 132.7%, reaching $4.24, while Psyence Biomedical (PBM) rose 92.23% to $14.61. Other notable gainers included Theriva Biologics (TOVX) up 75.23%, and Clearmind Medicine (CMND) up 59.82%. Conversely, Passage Bio (PASG) dropped 36.3% to $7.43, and AnaptysBio (ANAB) fell 25.85% to $50.06. Overall, several health care stocks experienced notable fluctuations in their market values during the session." datetime: "2026-04-20T17:05:50.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/283385887.md) - [en](https://longbridge.com/en/news/283385887.md) - [zh-HK](https://longbridge.com/zh-HK/news/283385887.md) --- # 12 Health Care Stocks Moving In Monday's Intraday Session ### Gainers - **Enveric Biosciences** (NASDAQ:ENVB) shares increased by 132.7% to $4.24 during Monday's regular session. The company's market cap stands at $2.5 million. - **Psyence Biomedical** (NASDAQ:PBM) shares rose 92.23% to $14.61. The market value of their outstanding shares is at $7.7 million. - **Theriva Biologics** (AMEX:TOVX) shares rose 75.23% to $0.45. The company's market cap stands at $11.8 million. - **Clearmind Medicine** (NASDAQ:CMND) stock rose 59.82% to $1.15. The company's market cap stands at $1.7 million. - **Compass Pathways** (NASDAQ:CMPS) stock increased by 49.32% to $9.95. The market value of their outstanding shares is at $898.5 million. - **Cue Biopharma** (NASDAQ:CUE) shares increased by 30.74% to $0.79. The company's market cap stands at $59.2 million. ### Losers - **Passage Bio** (NASDAQ:PASG) stock decreased by 36.3% to $7.43 during Monday's regular session. The market value of their outstanding shares is at $37.0 million. - **AnaptysBio** (NASDAQ:ANAB) shares decreased by 25.85% to $50.06. The company's market cap stands at $1.8 billion. - **Nano X Imaging** (NASDAQ:NNOX) stock fell 25.26% to $2.13. The company's market cap stands at $166.7 million. As per the press release, Q4 earnings came out today. - **CEL-SCI** (AMEX:CVM) shares declined by 23.24% to $3.8. The market value of their outstanding shares is at $41.8 million. - **Agios Pharmaceuticals** (NASDAQ:AGIO) stock declined by 23.14% to $27.01. The company's market cap stands at $2.0 billion. - **Aditxt** (NASDAQ:ADTX) stock fell 22.64% to $0.34. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [TOVX.US](https://longbridge.com/en/quote/TOVX.US.md) - [PASG.US](https://longbridge.com/en/quote/PASG.US.md) - [CMND.US](https://longbridge.com/en/quote/CMND.US.md) - [ANAB.US](https://longbridge.com/en/quote/ANAB.US.md) - [ENVB.US](https://longbridge.com/en/quote/ENVB.US.md) - [PBM.US](https://longbridge.com/en/quote/PBM.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [CMPS.US](https://longbridge.com/en/quote/CMPS.US.md) - [CUE.US](https://longbridge.com/en/quote/CUE.US.md) - [NNOX.US](https://longbridge.com/en/quote/NNOX.US.md) - [CVM.US](https://longbridge.com/en/quote/CVM.US.md) - [AGIO.US](https://longbridge.com/en/quote/AGIO.US.md) - [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md) - [PBMWW.US](https://longbridge.com/en/quote/PBMWW.US.md) ## Related News & Research - [AnaptysBio shifts fiscal year-end to June 30 from Dec. 31](https://longbridge.com/en/news/287267219.md) - [Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing | PBM Stock News](https://longbridge.com/en/news/286572370.md) - [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md) - [Lynozyfic® shows quick, significant responses in all second-line-plus systemic AL amyloidosis patients.](https://longbridge.com/en/news/287274655.md) - [Leerink Partners Sticks to Their Buy Rating for Ibio (IBIO)](https://longbridge.com/en/news/286588262.md)